Harmonization of immune biomarker assays for clinical studies (Q37954593)

25 August 2017

Harmonization of immune biomarker assays for clinical studies (English)

1 reference

25 August 2017

0 references

Christian H. Ottensmeier

5

1 reference

25 August 2017

3

Cécile Gouttefangeas

1 reference

25 August 2017

Sjoerd H van der Burg

1

object named as

Sjoerd H van der Burg

1 reference

25 August 2017

Michael Kalos

2

1 reference

25 August 2017

Sylvia Janetzki

4

1 reference

25 August 2017

Marij J P Welters

6

1 reference

25 August 2017

Pedro Romero

7

1 reference

25 August 2017

Cedrik M Britten

8

1 reference

25 August 2017

Axel Hoos

9

1 reference

25 August 2017

language of work or name

English

0 references

publication date

1 November 2011

1 reference

Science Translational Medicine

25 August 2017

1 reference

25 August 2017

3

1 reference

25 August 2017

108ps44

1 reference

25 August 2017

108

1 reference

Immune therapy for cancer

25 August 2017

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3002785

The three Es of cancer immunoediting

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3002785

Prostate cancer as a model for tumour immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3002785

Molecularly defined vaccines for cancer immunotherapy, and protective T cell immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3002785

Adoptive T cell therapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3002785

T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3002785

T-cell engineering for cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3002785

A clinical development paradigm for cancer vaccines and related biologics

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3002785

Improved endpoints for cancer immunotherapy trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3002785

"MIATA"-minimal information about T cell assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3002785

Harmonization guidelines for HLA-peptide multimer assays derived from results of a large scale international proficiency panel of the Cancer Vaccine Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3002785

Toward the harmonization of immune monitoring in clinical trials: quo vadis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3002785

Results and harmonization guidelines from two large-scale international Elispot proficiency panels conducted by the Cancer Vaccine Consortium (CVC/SVI)

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3002785

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3002785

Sipuleucel-T immunotherapy for castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3002785

Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3002785

Success or failure of vaccination for HPV16-positive vulvar lesions correlates with kinetics and phenotype of induced T-cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3002785

An integrative paradigm to impart quality to correlative science

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3002785

Response definition criteria for ELISPOT assays revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3002785

Serum is not required for ex vivo IFN-gamma ELISPOT: a collaborative study of different protocols from the European CIMT Immunoguiding Program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3002785

Performance of serum-supplemented and serum-free media in IFNgamma Elispot Assays for human T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3002785

A critical assessment for the value of markers to gate-out undesired events in HLA-peptide multimer staining protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3002785

Minimal information about T cell assays: the process of reaching the community of T cell immunologists in cancer and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3002785

Modeling flow cytometry data for cancer vaccine immune monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3002785

Single-institution experience with ipilimumab in advanced melanoma patients in the compassionate use setting: lymphocyte count after 2 doses correlates with survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3002785

Quality assurance of intracellular cytokine staining assays: analysis of multiple rounds of proficiency testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3002785

A model for harmonizing flow cytometry in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3002785

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3002785

A methodological framework to enhance the clinical success of cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3002785

10.1126/SCITRANSLMED.3002785

21 January 2018

Identifiers

DOI

1 reference

25 August 2017

1 reference